Nobuhiro Tsuchiya

发表

Prognostic Factors Affecting Short- and Long-Term Outcomes of Gastrectomy for Gastric Cancer in Older Patients

C. Kunisaki, T. Kosaka, H. Akiyama, 2022, Digestive Surgery.

Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma

Shinichirou Takahashi, N. Gotohda, M. Konishi, 2016, Oncotarget.

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate

S. Kaneko, Y. Uemura, T. Nakatsura, 2016, International journal of oncology.

Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice.

T. Uchida, Y. Uemura, T. Nakatsura, 2016, Biochemical and biophysical research communications.

Solitary living worsens the continuation of adjuvant chemotherapy for gastric cancer.

C. Kunisaki, S. Nagasawa, Y. Rino, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

C. Kunisaki, T. Kosaka, H. Akiyama, 2022, Langenbeck's Archives of Surgery.

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

I. Endo, J. Furuse, M. Ikeda, 2016, Oncoimmunology.

Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.

I. Endo, T. Kaisho, S. Senju, 2019, Cell reports.

Induced pluripotent stem cell-derived, genetically engineered myeloid cells as unlimited cell source for dendritic cell-related cancer immunotherapy

I. Endo, H. Ohdan, S. Senju, 2021 .

Cancer immunotherapy‐targeted glypican‐3 or neoantigens

I. Endo, Toshihiro Suzuki, T. Nakatsura, 2018, Cancer science.

Biomarkers for the early diagnosis of hepatocellular carcinoma.

Keigo Saito, Itaru Endo, I. Endo, 2015, World journal of gastroenterology.

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma

I. Endo, S. Mizuno, T. Nakatsura, 2017, Oncoimmunology.

Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection

I. Endo, T. Murakami, R. Matsuyama, 2019, World Journal of Surgery.

Potentiality of immunotherapy against hepatocellular carcinoma.

I. Endo, Y. Uemura, T. Nakatsura, 2015, World journal of gastroenterology.

Systemic Review and Meta-analysis of Impact of Splenectomy for Advanced Gastric Cancer

I. Endo, C. Kunisaki, T. Kosaka, 2020, In Vivo.

Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy

I. Endo, T. Murakami, R. Matsuyama, 2020, World Journal of Surgery.

Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative Resection

I. Endo, T. Murakami, R. Matsuyama, 2019, AntiCancer Research.

Rex Shunt for Bleeding Jejunal Limb Varices Caused by Extrahepatic Portal Vein Obstruction after Pancreatoduodenectomy

I. Endo, D. Morioka, R. Matsuyama, 2020, The Japanese Journal of Gastroenterological Surgery.

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors

A. Manabe, K. Yoshimura, A. Hosono, 2017, Oncoimmunology.

Prognostic impact of dimensional factors in pT1 gastric cancer.

I. Endo, C. Kunisaki, Masazumi Takahashi, 2021, Surgical oncology.

Impact of intramuscular adipose tissue content on short- and long-term outcomes of hepatectomy for colorectal liver metastasis: a retrospective analysis

I. Endo, D. Morioka, T. Murakami, 2020, World Journal of Surgical Oncology.

Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells.

I. Endo, T. Kaisho, S. Senju, 2019, Cell reports.

Feasibility of esophagectomy for esophageal cancer in elderly patients: a case–control study

I. Endo, C. Kunisaki, T. Kosaka, 2021, Langenbeck's Archives of Surgery.

Comparison of Converse Ω Anastomosis and Extracorporeal Anastomosis After Laparoscopic Distal Gastrectomy for Gastric Cancer

I. Endo, C. Kunisaki, H. Miyamoto, 2021, Surgical laparoscopy, endoscopy & percutaneous techniques.

Future prospects for cancer immunotherapy using induced pluripotent stem cell‐derived dendritic cells or macrophages

S. Fukushima, Y. Uemura, Rong Zhang, 2022, Experimental dermatology.

High postoperative neutrophil–lymphocyte ratio and low preoperative lymphocyte-monocyte ratio predict poor prognosis in gastric cancer patients receiving gastrectomy with positive lavage cytology: a retrospective cohort study

I. Endo, C. Kunisaki, H. Miyamoto, 2021, Langenbeck's Archives of Surgery.

Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer

C. Kunisaki, J. Kimura, H. Makino, 2023, AntiCancer Research.

Real-World Therapeutic Outcomes of S-1 Adjuvant Chemotherapy for pStage II/III Gastric Cancer in the Elderly

I. Endo, C. Kunisaki, T. Kosaka, 2021, European Surgical Research.

Is Prophylactic Splenectomy Necessary for Proximal Advanced Gastric Cancer Invading the Greater Curvature with Clinically Negative Splenic Hilar Lymph Node Metastasis? A Multi-Institutional Cohort Study (YCOG2003)

C. Kunisaki, J. Kimura, H. Makino, 2022, Annals of Surgical Oncology.

Feasibility of Laparoscopy-assisted Gastrectomy for Gastric Cancer in Elderly Patients: A Case-Control Study

I. Endo, T. Yamanaka, C. Kunisaki, 2018, Surgical laparoscopy, endoscopy & percutaneous techniques.